These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 10152244)

  • 21. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Giulio Formoso, per l'Associazione Alessandro Liberati - Network italiano Cochrane
    Recenti Prog Med; 2019 Nov; 110(11):524-525. PubMed ID: 31808432
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raw data from clinical trials: within reach?
    Doshi P; Goodman SN; Ioannidis JP
    Trends Pharmacol Sci; 2013 Dec; 34(12):645-7. PubMed ID: 24295825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy assessment criteria based on risk and cost.
    MacIntyre NR
    Respir Care; 1995 Sep; 40(9):968-70. PubMed ID: 10152241
    [No Abstract]   [Full Text] [Related]  

  • 27. How do we know what we know? The randomized controlled trial revisited.
    Heaney RP
    J Bone Miner Res; 1991 Feb; 6(2):103-5. PubMed ID: 2028831
    [No Abstract]   [Full Text] [Related]  

  • 28. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement?
    Ozdemir V; Joly Y; Knoppers BM
    Am J Bioeth; 2011 Mar; 11(3):11-3. PubMed ID: 21400375
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 31. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pragmatic randomized controlled trials as a source of data in the assessment of effectiveness of medical technology].
    Kaczyński L; Solnica B
    Przegl Lek; 2012; 69(9):703-7. PubMed ID: 23401993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems of using modelling in the economic evaluation of health care.
    Sheldon TA
    Health Econ; 1996; 5(1):1-11. PubMed ID: 8653188
    [No Abstract]   [Full Text] [Related]  

  • 34. Fables or foibles: inherent problems with RCTs.
    Rosner A
    J Manipulative Physiol Ther; 2003 Sep; 26(7):460-7. PubMed ID: 12975633
    [No Abstract]   [Full Text] [Related]  

  • 35. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global benefit-risk assessment in designing clinical trials and some statistical considerations of the method.
    Pritchett YL; Tamura R
    Pharm Stat; 2008; 7(3):170-8. PubMed ID: 17538942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of randomized controlled trials.
    Stanley K
    Circulation; 2007 Apr; 115(13):1819-22. PubMed ID: 17404173
    [No Abstract]   [Full Text] [Related]  

  • 39. Bias control in clinical trials: masking or blinding.
    Galvez-Olortegui JK; Gonzales-Saldaña J; Garcia-Gomez I; Silva-Ocas I; Gutierrez-Arana J; Galvez-Olortegui T; Condor-Rojas YC
    Medwave; 2015 Dec; 15(11):e6349. PubMed ID: 26731671
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.